This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Revenues of Edwards Lifesciences Corporation with missing and latest data points interpolated. Revenues refers to the total amount of money received by Edwards Lifesciences for goods sold or services provided during a certain time period. It also includes all of Edwards Lifesciences sales as well as any other increase in Edwards Lifesciences Corporation equity.Revenues are reported on Edwards Lifesciences income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
|10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Edwards Lifesciences Revenues Over Time